Indexed keywords
(1,4 DIOXO 1,4 DIHYDROANTHRACENYL)METHYL DI TERT BUTYL PHOSPHATE;
1,4 ANTHRACENEDIONE;
1,4 BENZOQUINONE;
2 (METHYLAMINO) 1,4 ANTHRACENEDIONE;
2 (METHYLAMINO) 6,7 DICHLORO 1,4 ANTHRACENEDIONE;
2 BROMO 6 METHYL 1,4 ANTHRACENEDIONE;
2 BROMO 7 METHYL 1,4 ANTHRACENEDIONE;
5,8 DIOXO 5,8 DIHYDRO 2 ANTHRACENYLMETHYL 1,3,4,5 TETRAHYDROXYCYCLOHEXANE CARBOXYLATE;
5,8 DIOXO 5,8 DIHYDROXYANTHRACENE 2 CARBOXYLIC ACID;
6 BROMOMETHYL 1,4 ANTHRACENEDIONE;
6 FORMYL 1,4 ANTHRACENEDIONE;
6 FORMYL 1,5 ANTHRACENEDIONE;
6 HYDROXY 1,4 ANTHRACENEDIONE;
6 METHYL 1,4 ANTHRACENEDIONE;
6 METHYL 1,4 DIHYDROXYANTHRAQUINONE;
6,7 DICHLORO 1,4 ANTHRACENEDIONE;
6,7 DICHLORO 1,4 DIHYDROXY 9,10 ANTHRAQUINONE;
ALCOHOL;
ALDEHYDE;
ALKYL GROUP;
ANTHRACENE DERIVATIVE;
BROMIDE;
DAUNORUBICIN;
N [(1,4 DIOXO 1,4 DIHYDROANTHRACENYL)METHYL] 2 AMINO 2 DEOXY 1,3,4,6 TETRA O ACETYL BETA DEXTRO GLUCOPYRANOSE;
N [(1,4 DIOXO 1,4 DIHYDROANTHRACENYL)METHYLIDENE] 2 AMINO 2 DEOXY 1,3,4,6 TETRA O ACETYL BETA DEXTRO GLUCOPYRANOSE;
ORGANOPHOSPHATE;
PRODRUG;
UNCLASSIFIED DRUG;
WATER;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BROMINATION;
CANCER INHIBITION;
CELL VIABILITY;
CHEMICAL MODIFICATION;
CHEMICAL REACTION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOSTASIS;
CYTOTOXICITY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SCREENING;
DRUG SENSITIVITY;
DRUG SYNTHESIS;
DRUG TARGETING;
FRIEDEL CRAFTS REACTION;
HEALTH CARE ORGANIZATION;
HUMAN;
HUMAN CELL;
HYDROLYSIS;
IN VITRO STUDY;
INHIBITION KINETICS;
LEUKEMIA CELL;
MOLECULAR MECHANICS;
MOUSE;
NONHUMAN;
OXIDATION;
PRIORITY JOURNAL;
REACTION ANALYSIS;
SOLUBILITY;
TUMOR CELL;
TUMOR CELL LINE;
MURINAE;
1
0001530185
Daunomycin: (a) A. Di Marco, M. Gaetani, P. Orezzi, B.M. Scarpinato, R. Silvestrini, M. Soldati, T. Dasdia, and L. Valentini Nature 201 1964 706 707
(1964)
Nature
, vol.201
, pp. 706-707
Di Marco, A.1
Gaetani, M.2
Orezzi, P.3
Scarpinato, B.M.4
Silvestrini, R.5
Soldati, M.6
Dasdia, T.7
Valentini, L.8
3
4644373447
Anthracycline Antibiotics, New Analogues, Methods of Delivery, and Mechanisms of Action
For reviews, see: (a) Anthracycline Antibiotics, New Analogues, Methods of Delivery, and Mechanisms of Action. Priebe, W., Ed.; American Chemical Society Symposium Series 574; 1993.
(1993)
American Chemical Society Symposium Series 574
Priebe, W.1
5
0038155211
H.-S. Huang, J.-F. Chiou, Y. Fong, C.-C. Hou, Y.-C. Lu, J.-Y. Wang, J.-W. Shih, Y.-R. Pan, and J.-J. Lin J. Med. Chem. 46 2003 3300 3307
(2003)
J. Med. Chem.
, vol.46
, pp. 3300-3307
Huang, H.-S.1
Chiou, J.-F.2
Fong, Y.3
Hou, C.-C.4
Lu, Y.-C.5
Wang, J.-Y.6
Shih, J.-W.7
Pan, Y.-R.8
Lin, J.-J.9
7
13344283409
For recent reviews: (e) A.P. Krapcho, M.J. Maresch, M.P. Hacker, L. Hazelhurst, E. Menta, A. Oliva, S. Spinelli, G. Beggiolin, F.C. Giuliani, G. Pezzoni, and S. Tognella Curr. Med. Chem. 2 1995 803 824
(1995)
Curr. Med. Chem.
, vol.2
, pp. 803-824
Krapcho, A.P.1
Maresch, M.J.2
Hacker, M.P.3
Hazelhurst, L.4
Menta, E.5
Oliva, A.6
Spinelli, S.7
Beggiolin, G.8
Giuliani, F.C.9
Pezzoni, G.10
Tognella, S.11
13
0000676319
N. Martin, J. Segura, C. Seoane, P. de la Cruz, F. Langa, E. Orti, P.M. Viruela, and R. Viruela J. Org. Chem. 60 1995 4077 4084
(1995)
J. Org. Chem.
, vol.60
, pp. 4077-4084
Martin, N.1
Segura, J.2
Seoane, C.3
De La Cruz, P.4
Langa, F.5
Orti, E.6
Viruela, P.M.7
Viruela, R.8
14
0027238494
E. Barranco, N. Martin, J.L. Segura, C. Seoane, P. de la Cruz, F. Langa, A. Gonzalez, and J.M. Pingarron Tetrahedron 49 1993 4881 4892
(1993)
Tetrahedron
, vol.49
, pp. 4881-4892
Barranco, E.1
Martin, N.2
Segura, J.L.3
Seoane, C.4
De La Cruz, P.5
Langa, F.6
Gonzalez, A.7
Pingarron, J.M.8
15
0025044220
M. Anastasia, P. Allevi, C. Bettini, A. Fiecchi, and A.M. Sanvito Synthesis 1990 1083 1084
(1990)
Synthesis
, pp. 1083-1084
Anastasia, M.1
Allevi, P.2
Bettini, C.3
Fiecchi, A.4
Sanvito, A.M.5
19
0033910817
E.M. Perchellet, M.J. Magill, X. Huang, D.M. Dalke, D.H. Hua, and J.-P. Perchellet Anti-Cancer Drugs 11 2000 339 352
(2000)
Anti-Cancer Drugs
, vol.11
, pp. 339-352
Perchellet, E.M.1
Magill, M.J.2
Huang, X.3
Dalke, D.M.4
Hua, D.H.5
Perchellet, J.-P.6
21
0028788959
G. Sartori, F. Bigi, X. Tao, C. Porta, R. Maggi, G. Predieri, M. Lanfranchi, and M.A. Pellinghelli J. Org. Chem. 60 1995 6588 6591
(1995)
J. Org. Chem.
, vol.60
, pp. 6588-6591
Sartori, G.1
Bigi, F.2
Tao, X.3
Porta, C.4
Maggi, R.5
Predieri, G.6
Lanfranchi, M.7
Pellinghelli, M.A.8
34
0000146455
E.M. Perchellet, M.J. Magill, X. Huang, C.E. Brantis, D.H. Hua, and J.-P. Perchellet Anti-cancer Drugs 10 1999 749 766
(1999)
Anti-cancer Drugs
, vol.10
, pp. 749-766
Perchellet, E.M.1
Magill, M.J.2
Huang, X.3
Brantis, C.E.4
Hua, D.H.5
Perchellet, J.-P.6
35
0035217579
M. Wu, B. Wang, E.M. Perchellet, B.J. Sperfslage, H.A. Stephany, D.H. Hua, and J.P. Perchellet Anti-Cancer Drugs 12 2001 807 819
(2001)
Anti-Cancer Drugs
, vol.12
, pp. 807-819
Wu, M.1
Wang, B.2
Perchellet, E.M.3
Sperfslage, B.J.4
Stephany, H.A.5
Hua, D.H.6
Perchellet, J.P.7
36
1242331010
E.M. Perchellet, Y. Wang, R.L. Weber, B.J. Sperfslage, K. Lou, J. Crossland, D.H. Hua, and J.P. Perchellet Biochem. Pharmacol. 67 2004 523 537
(2004)
Biochem. Pharmacol.
, vol.67
, pp. 523-537
Perchellet, E.M.1
Wang, Y.2
Weber, R.L.3
Sperfslage, B.J.4
Lou, K.5
Crossland, J.6
Hua, D.H.7
Perchellet, J.P.8
37
2542433705
Sept 7-11, New York, NY: ACS Division of Medicinal Chemistry, Abstract 272.
Wang, Y.; Ward, M. M.; Perchellet, E. M.; Lou, K.; Crossland, J.; Hua, D. H.; Perchellet, J. P. 226th American Chemical Society National Meeting, Sept 7-11, 2003; New York, NY: ACS Division of Medicinal Chemistry, Abstract 272.
(2003)
226th American Chemical Society National Meeting
Wang, Y.1
Ward, M.M.2
Perchellet, E.M.3
Lou, K.4
Crossland, J.5
Hua, D.H.6
Perchellet, J.P.7
38
0037012889
D.H. Hua, M. Tamura, X. Huang, H. Stephany, B.A. Helfrich, E.M. Perchellet, B.J. Sperfslage, J.-P. Perchellet, S. Jiang, D.E. Kyle, and P.K. Chiang J. Org. Chem. 67 2002 2907 2912
(2002)
J. Org. Chem.
, vol.67
, pp. 2907-2912
Hua, D.H.1
Tamura, M.2
Huang, X.3
Stephany, H.4
Helfrich, B.A.5
Perchellet, E.M.6
Sperfslage, B.J.7
Perchellet, J.-P.8
Jiang, S.9
Kyle, D.E.10
Chiang, P.K.11